EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned

Timothy Beukelman iD, Lang Chen, Narender Annapureddy, Jim Oates, Megan E B Clowse, Millie Long, Michael D Kappelman, Rennie L Rhee, Peter A Merkel, William Benjamin Nowell, Fenglong Xie iD, Cassie Clinton und 1 weitere

Pharmacoepidemiology and Drug Safety · 2023-09 · 32 (9) · 969-977

DOI: 10.1002/pds.5627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 15.04.2023. Verfasst von Timothy Beukelman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Electronic Health Records, Pharmacoepidemiology. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We assessed the suitability of pooled electronic health record (EHR) data from clinical research networks (CRNs) of the patient‐centered outcomes research network to conduct studies of the association between tumor necrosis factor inhibitors (TNFi) and infections.

Methods

EHR data from patients with one of seven autoimmune diseases were obtained from three CRNs and pooled. Person‐level linkage of CRN data and Centers for Medicare and Medicaid Services (CMS) fee‐for‐service claims data was performed where possible. Using filled prescriptions from CMS claims data as the gold standard, we assessed the misclassification of EHR‐based new (incident) user definitions. Among new users of TNFi, we assessed subsequent rates of hospitalized infection in EHR and CMS data.

Results

The study included 45 483 new users of TNFi, of whom 1416 were successfully linked to their CMS claims. Overall, 44% of new EHR TNFi prescriptions were not associated with medication claims. Our most specific new user definition had a misclassification rate of 3.5%–16.4% for prevalent use, depending on the medication. Greater than 80% of CRN prescriptions had either zero refills or missing refill data. Compared to using EHR data alone, there was a 2‐ to 8‐fold increase in hospitalized infection rates when CMS claims data were added to the analysis.

Conclusions

EHR data substantially misclassified TNFi exposure and underestimated the incidence of hospitalized infections compared to claims data. EHR‐based new user definitions were reasonably accurate. Overall, using CRN data for pharmacoepidemiology studies is challenging, especially for biologics, and would benefit from supplementation by other sources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Health RecordsPharmacoepidemiologyAgedHumansUnited StatesMedicarePrescriptionsCenters for Medicare and Medicaid Services, U.S.

Stichwörter der Autor:innen

biological therapyelectronic health recordsinfectionspharmacoepidemiology

Autor:innen und Institutionen

  • Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Division of Rheumatology and Immunology, Duke University, Durham, North Carolina, USA.
  • Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Timothy Beukelman, Fenglong Xie

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Beukelman, T., Chen, L., Annapureddy, N., Oates, J., Clowse, M. E. B., Long, M., Kappelman, M. D., Rhee, R. L., Merkel, P. A., Nowell, W. B., Xie, F., Clinton, C., & Curtis, J. R. (2023). Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned. Pharmacoepidemiology and Drug Safety, 32(9), 969-977. https://doi.org/10.1002/pds.5627

Vancouver

Beukelman T, Chen L, Annapureddy N, Oates J, Clowse MEB, Long M, et al. Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned. Pharmacoepidemiology and Drug Safety. 2023;32(9):969-977. doi:10.1002/pds.5627

BibTeX
@article{Beukelman2023,
  author = {Beukelman, Timothy and Chen, Lang and Annapureddy, Narender and Oates, Jim and Clowse, Megan E B and Long, Millie and Kappelman, Michael D and Rhee, Rennie L and Merkel, Peter A and Nowell, William Benjamin and Xie, Fenglong and Clinton, Cassie and Curtis, Jeffrey R},
  title = {Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2023},
  volume = {32},
  number = {9},
  pages = {969--977},
  doi = {10.1002/pds.5627}
}
Kostenlos starten →